Marloes C. De Bruijni
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The kinetics and transmission-blocking dynamics of P. falciparum sexual-stage antibody responses in a six-year cohort of Ugandan children and adults.
Journal: Research square
Published: February 23, 2026
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross-stage recognition of glutamate-rich repeats.
Journal: eLife
Published: January 16, 2025
2,8-Disubstituted-1,5-naphthyridines as Dual Inhibitors of Plasmodium falciparum Phosphatidylinositol-4-kinase and Hemozoin Formation with In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: June 25, 2024
Target-agnostic identification of human antibodies to Plasmodium falciparum sexual forms reveals cross stage recognition of glutamate-rich repeats.
Journal: bioRxiv : the preprint server for biology
Published: November 14, 2023
Molecular determinants of cross-reactivity and potency by VH3-33 antibodies against the Plasmodium falciparum circumsporozoite protein.
Journal: Cell reports
Published: July 23, 2023
Assessment of the drugability of initial malaria infection through miniaturized sporozoite assays and high-throughput screening.
Journal: Communications biology
Published: October 12, 2022
Potent transmission-blocking monoclonal antibodies from naturally exposed individuals target a conserved epitope on Plasmodium falciparum Pfs230.
Journal: Immunity
Published: August 16, 2022
Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes.
Journal: Immunity
Published: August 15, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026